Incorrect Affiliation
In the published article, there was an error in affiliations 1 and 2. Instead of “1Basic Medical College, Henan University of Science and Technology, Luoyang, China, 2Henan International Joint Laboratory of Thrombosis and Hemostasis, Henan University of Science and Technology, Luoyang, China”, it should be “1Henan International Joint Laboratory of Thrombosis and Hemostasis, Henan University of Science and Technology, Luoyang, China, 2Basic Medical College, Henan University of Science and Technology, Luoyang, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
poly(rC)-binding proteins, hematopoiesis, hematological malignancy, mRNA stability, alternative splicing
Citation
Zhao H, Wei Z, Shen G, Chen Y, Hao X, Li S and Wang R (2023) Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy. Front. Oncol. 12:1132485. doi: 10.3389/fonc.2022.1132485
Received
27 December 2022
Accepted
30 December 2022
Published
14 February 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2023 Zhao, Wei, Shen, Chen, Hao, Li and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xueqin Hao, haoxueqin@haust.edu.cn; Sanqiang Li, sanqiangli2001@163.com; Rong Wang, wangrong36602010@163.com
This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.